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1 |  INTRODUCTION
Cryoglobulinemia can occur secondary to infections, auto-
immune diseases or be idiopathic. Making a confident over-
arching diagnosis can be challenging. We describe a case of 
cryoglobulinemia in a patient with recent hepatitis A infec-
tion and multisystem features and outline the clinical course 
that led us to diagnose systemic lupus erythematosus.
Cryoglobulins are immunoglobulins that precipitate at 
temperatures below 37°C and cause clinical manifestations 
through the creation of a hyperviscous state or immune 
complex- mediated disease. Type I cryoglobulins comprise 
monoclonal IgM or IgG, type II comprise monoclonal IgM 
with rheumatoid factor activity and polyclonal IgG, and type 
III are a mixture of polyclonal IgM and IgG. Type II and III 
cryoglobulinemia typically occur secondary to underlying in-
fection, autoimmune conditions or malignancy. Around 10% 
of cases are idiopathic, termed essential cryoglobulinemia.1 
Knowledge of the wide range of primary causes is essential 
for workup and guiding treatment.1,2
While some primary causes of cryoglobulinemia are 
easily identified through serological tests, for example 
viral hepatitis, others are more challenging. Systemic 
lupus erythematosus is a complex autoimmune disease 
associated with a range of autoantibodies. It involves 
multiple organ systems and has wide variations in symp-
tomatology. The average time between first symptoms 
and SLE diagnosis is 6 years, and nearly half of individ-
uals receive an alternative initial diagnosis.3 Diagnostic 
criteria require a positive ANA with at least one clin-
ical criterion and a score of 10 or more on a domain- 
weighting system as demonstrated in Table 1.4 Of note, 
criteria do not need to occur simultaneously or be per-
sistently present.
We describe the clinical course that led to SLE 
being diagnosed in a patient with long- standing ANA 
positivity and multiple attendances to primary and 
secondary care, highlighting the importance of revis-
iting original diagnoses in individuals with atypical 
presentations.
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In cases with a broad differential or atypical features, it is important to continually 
review the original diagnosis. Diagnosing SLE can be challenging due to its multi-
system presentations; a multidisciplinary approach is beneficial.
K E Y W O R D S
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2 |  CASE HISTORY AND 
EXAMINATION
A 70- year- old woman was admitted to the medical unit with 
a 5- day history of a nonblanching petechial rash on her but-
tocks and lower limbs, and 3 days of nausea and vomiting 
without abdominal pain. She had no fever, photophobia or 
neck stiffness, no cough or shortness of breath, and no chest 
pain. She described diarrhea without blood or mucous. Her 
urine appeared frothy but she had no dysuria or visible he-
maturia. She had developed swelling in her feet and ankles.
Three months earlier, she had been admitted to hospital 
with jaundice. Her husband was unwell with the same symp-
toms after they shared a take- away meal. She was found to 
have acute hepatitis A with a positive IgM and negative IgG 
antibody; her husband was diagnosed with the same infection. 
Due to significant derangement in her liver function tests, slow 
clinical resolution and a positive antinuclear antibody (ANA), 
she underwent a liver biopsy to investigate for potential dual 
liver pathology. This showed multifocal hepatocellular ne-
crotic lesions, hepato- canalicular cholestasis, and mild mac-
rovesicular steatosis consistent with acute cholestatic hepatitis 
secondary to hepatitis A. At the time, her serum creatinine was 
93 µmol/L with an eGFR of 43 mL/min/1.73 m2, stable from 
3 years previously. She had been slowly recovering from this 
illness, only recently returning to her previous level of health.
Past medical history included a 30- year history of hyperten-
sion and preeclampsia in her two pregnancies. She had hyper-
thyroidism with a positive anti- thyroid peroxidase antibody, 
for which she had received radio- iodine treatment, and a long 
history of lethargy and myalgia diagnosed as chronic fatigue 
syndrome by her GP. She had prediabetes under surveillance. 
Two years previously a coincidental finding of deranged liver 
function tests had been detected on routine blood tests. An 
autoimmune liver screen detected positive ANA and smooth 
muscle antibodies. A liver ultrasound was normal, and no de-
finitive diagnosis was made. Her liver function spontaneously 
improved, and she had been discharged from follow- up.
She had no recent foreign travel and no pets. She was a 
retired nurse with no history of alcohol excess, recreational 
drug use, tattoos, or blood transfusions. There was no signif-
icant family history.
On physical examination, she was hypertensive with a 
blood pressure of 188/78 mm Hg, oxygen saturations of 98% 
on room air and had no fever. Body mass index was 32 kg/
m2. There were no splinter hemorrhages or lymphadenopa-
thy. She had a soft pan- systolic murmur, chest examination 
revealed good bilateral air entry, and the abdomen was soft 
with no palpable masses. There was a purpuric rash most 
prominent on her lower limbs and buttocks. She had pitting 
edema to her ankles and sacrum.
On admission, blood tests showed a raised serum creatinine at 
181 µmol/L with urea 12.5 mmol/L, a low sodium at 130 mmol/L, 
and normal potassium at 4.7 mmol/L. Baseline creatinine was 95 
µmol/L. Corrected calcium, phosphate, and glucose were nor-
mal. Liver function showed a normal bilirubin (8 µmol/L, peak 
297 µmol/L during hepatitis A), mildly elevated ALT at 78 U/L 
(peak 970 U/L during hepatitis A), and a normal ALP.
Full blood count showed a mild normocytic anemia with 
hemoglobin 108 g/L, normal white cell count at 5.68 × 109/L, 
and a thrombocytopenia with platelets 88  ×  109/L. A 
blood clotting profile was normal. Haptoglobin was low at 
<0.03 g/L but lactate dehydrogenase only slightly elevated at 
503 U/L. C- reactive protein was mildly elevated at 18 mg/L.
Urinalysis was positive for blood and protein. Urine pro-
tein:creatinine ratio was elevated at 461 mg/mmol with low 
serum albumin at 26 g/L.
Immunology revealed a positive ANA but extranuclear 
antigens (SS- A, SS- B, Sm, RNP, Jo1, Scl70, and dsDNA) 











Subacute cutaneous or discoid 
lupus erythematosus
4
Acute cutaneous lupus 
erythematosus
6





Renal Proteinuria >0.5 g/24 hours 4
Class II/V lupus nephritis on 
renal biopsy
8







β2GPI antibodies or lupus 
anticoagulant
2
Complement C3 or C4 low 3
C3 and C4 low 4
SLE- specific antibodies Anti- Sm 6
Anti- dsDNA 6
Note: In people who have ever had a positive ANA test, a score ≥10 has a 
sensitivity of 96.1% and specificity of 93.4% for diagnosis. The domains 
relevant to our patient are shown in bold.
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were negative. Anticardiolipin antibody and rheumatoid 
factor were normal. C4 was low at 0.06  g/L and C3 nor-
mal at 1.18 g/L. Serum and urine electrophoresis were neg-
ative with a normal serum kappa:lambda light chain ratio. 
Immunoglobulins were normal (IgG 11.48 g/L, IgA 2.66 g/L, 
IgM 0.71 g/L). Type III cryoglobulins were detected.
Three sets of blood cultures and a urine culture showed no 
growth. Hepatitis A IgG was positive, and hepatitis A IgM 
was negative. Hepatitis B and C serology were negative. She 
had 3 equivocal HIV antibody tests, but HIV PCR was nega-
tive. Thiopurine methyltransferase level was low.
An abdominal ultrasound showed normal appearance of 
kidneys, liver, and spleen, and chest X- ray was normal. A 
transthoracic echocardiogram showed posterior mitral valve 
prolapse with mild mitral regurgitation and a small echogenic 
structure on the posterior leaflet. A transesophageal echocar-
diogram demonstrated thickening and echogenicity of the 
anterior and posterior leaflets of the mitral valve suggestive 
of a systemic inflammatory process, not typical for infective 
endocarditis. A skin biopsy was not performed as the rash 
spontaneously resolved.
A kidney biopsy was performed. This showed endocap-
illary and mesangial proliferation in 7 out of 9 glomeruli 
with focal double contours of the basement membrane, typi-
cal of an membranoproliferative glomerular injury (MPGN) 
(Figures 1 and 2). The remaining 2 glomeruli were globally 
sclerosed. On immunohistochemistry C3, IgG, IgM, and C1q 
showed strong mesangial and subendothelial positivity, and 
mild IgA positivity suggesting the “full- house” pattern of 
lupus nephritis. The arteries appeared normal. There was ev-
idence of mild chronicity with 15% interstitial fibrosis and 
tubular atrophy. On electron microscopy, granular suben-
dothelial electron- dense deposits were observed (Figure 3). 
There were no organized deposits, no tubuloreticular inclu-
sions, and no subepithelial humps.
3 |  DIFFERENTIAL DIAGNOSIS, 
INVESTIGATION, AND TREATMENT
The differential diagnosis was between an infective, autoim-
mune, or idiopathic cause of cryoglobulinemia. The main dif-
ferential within each category were as follows:
1. Cryoglobulinemia secondary to hepatitis A infection
2. Cryoglobulinemia secondary to SLE
3. Essential cryoglobulinemia
The recent hepatitis A infection and strong association be-
tween cryoglobulinemia and other viral hepatitides meant an 
infective cause was initially considered the most likely diagno-
sis. ANA positivity has also been described in up to half of in-
dividuals in the recovery phase of hepatitis A infection and can 
persist for up to 3 months.5 Further, as treatment of autoimmune 
F I G U R E  1  Silver stain of kidney biopsy demonstrating 
mesangial and endocapillary proliferation
F I G U R E  2  Periodic acid- Schiff stain of kidney biopsy 
demonstrating mesangial and endocapillary proliferation
F I G U R E  3  Electron microscopy of kidney biopsy demonstrating 
subendothelial electron- dense deposits
4 |   NIMMO et al.
or idiopathic cryoglobulinemia involves immunosuppression it 
was essential to investigate for underlying infection.
Hepatitis A induced cryoglobulinemia is encountered 
much less frequently than with other hepatitis viruses.6 Cases 
have typically been described in the acute phase of infection, 
with late cases only occurring in the context of relapsing or 
recurrent disease.7 Our patient had evidence of seroconver-
sion with a positive hepatitis A IgG and negative hepatitis A 
IgM alongside normalization of her liver function tests and 
synthetic liver function. These findings led us to consider 
other causes of cryoglobulinemia.
Several features of our patient's history stood out when 
considering autoimmune etiologies. She had a long history 
of constitutional symptoms, ANA positivity that pre- dated 
her hepatitis A infection, and a history of preeclampsia (more 
prevalent in women with SLE8), autoimmune thyroid disease 
and serositis (with prior deranged liver function and mitral 
valve thickening). These features raised the possibility of a 
long- standing rheumatologic diagnosis.
The kidney biopsy did not show intraluminal hyaline 
thrombi typical of cryoglobulinemic vasculitis, and the sub-
endothelial deposits on electron microscopy were granular 
rather than having the organized substructure typically seen 
with cryoglobulin deposition. No subepithelial humps were 
seen on electron microscopy, and so there was no convincing 
evidence of a postinfectious pathology.
Class III or class IV lupus nephritis can demonstrate 
an MPGN pattern as a result of endocapillary injury.9,10 
Alongside the full- house positivity on immunohistochemistry, 
the histological features were felt to most likely reflect lupus 
nephritis. The EULAR/ACR 2019 criteria (Table  1) were 
consulted, and a diagnosis of SLE was made given her ANA 
positivity alongside the presence of thrombocytopenia, hypo-
complementemia, proteinuria, and kidney biopsy findings.
Initial management was symptomatic with antiemetics, 
intravenous loop diuretic with oral thiazide diuretic, and a 
salt and 1 liter/day fluid restriction to manage her edema.
The risks and benefits of commencing immunosuppres-
sion for SLE were considered, compounded by the fact her 
presentation was during the COVID- 19 pandemic. Treatment 
options considered comprised oral corticosteroids with aza-
thioprine or mycophenolate mofetil. Removal of cryoglob-
ulins with plasma exchange or greater depletion of their 
production with rituximab was reserved in case of failure to 
respond to initial treatment.
Due to her low thiopurine methyltransferase level and 
recent deranged liver function tests, mycophenolate mofetil 
was favored and administered alongside 40 mg (0.5 mg/kg) 
oral prednisolone. Pulsed intravenous steroids and higher 
dose oral corticosteroids were avoided due to patient prefer-
ence alongside her history of prediabetes and elevated BMI. 
Hydroxychloroquine was commenced to reduce the risk of 
SLE- related end- organ damage.
4 |  OUTCOME AND FOLLOW- UP
Two weeks after commencing treatment, there were signs of 
clinical improvement. The patient noted an increase in urine 
output and reduction in edema, allowing a reduction in diu-
retic therapy. Six weeks after commencing treatment, her 
weight had dropped by 14 kg, her blood pressure had fallen, 
and antihypertensive agents were reduced. The patient re-
ported improved energy levels and greater overall well- being.
Her urine protein:creatinine ratio fell to 133  mg/mmol, 
with a corresponding rise in serum albumin to 37 g/L. Her 
renal function improved with a creatinine of 118 µmol/L and 
C4 rose to 0.24 g/L. A slow taper to her oral steroids was 
commenced. The patient remains clinically well at the time 
of writing. Of note, she remains ANA positive.
5 |  DISCUSSION
Cryoglobulinemia can present in a variety of ways. 
Hyperviscosity syndromes typically occur with type I cryo-
globulinemia in the context of hematological malignancy, 
presenting with headache, visual disturbance, and epistaxis. 
Cryoglobulinemic vasculitis is an immune complex- mediated 
disease. Constitutional symptoms such as malaise and low- 
grade fever are accompanied by a cutaneous purpuric rash 
in up to 80% of individuals. The kidneys are the next most 
frequently involved organ, and microscopic hematuria, pro-
teinuria, renal impairment, and hypertension are present in 
up to 20% of individuals. Peripheral neuropathy, gastrointes-
tinal, and respiratory symptoms can also occur.1
Hepatitis B and C infections are widely recognized causes 
of cryoglobulinemia.1 Hepatitis A- associated cryoglobulin-
emia is rare but has been described in case reports.7,11 While 
this seemed an attractive initial diagnosis, reports are of a 
type II cryoglobulinemia with positive rheumatoid factor 
occurring in the acute phase of the disease or in relapsing 
disease, contrary to what was observed here.7,11 In animal 
studies, a proliferative glomerulonephritis has been reported 
up to 25 weeks after the initial infection, but again in the con-
text of high antihepatitis A titres.12
An MPGN pattern of injury can be observed in a number of 
conditions. C3 dominance on immunofluorescence can associ-
ate with C3 glomerulopathy or dense deposit disease, while the 
presence of both immunoglobulin and complement staining can 
occur in infections, dysproteinemias and autoimmune diseases 
including SLE, Sjogren's, and rheumatoid arthritis. An MPGN 
pattern without immunoglobulin or complement staining can 
be seen in chronic thrombotic microangiopathy.13 In the con-
text of cryoglobulinemia, an MPGN pattern with deposition of 
immunoglobulins of the same type as those detected in serum 
is usually seen, with organized deposits in subendothelial and 
mesangial areas on electron microscopy.14 This pattern was not 
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shown in the biopsy of our case; however, characterizing the 
nature of deposits on electron microscopy can be challenging 
and the absence of typical cryoglobulin deposits cannot fully 
exclude a cryoglobulinemic glomerulonephritis.14
In our patient, the features that led us to a diagnosis of SLE 
were based on her history of preeclampsia, long- standing 
fatigue diagnosed as “Myalgic Encephalomyelitis,” autoim-
mune thyroid disease and evidence of hepatitis and endo-
carditis in the absence of infection, alongside long- standing 
positive ANA with low C4, thrombocytopenia and “full- 
house” positivity on kidney biopsy immunohistochemistry.4 
While many of the biochemical and pathological features can 
overlap with an infection- driven phenomenon, the absence of 
subepithelial humps on the kidney biopsy led us away from 
this and we were satisfied that occult infection had been thor-
oughly investigated for. The patient's response to immunosup-
pressive therapy, done with close supervision, was reassuring.
This case highlights several learning points. We discuss 
the broad categories within which cryoglobulinemia can 
occur and the potential causes of an MPGN pattern of injury 
on kidney biopsy. We demonstrate how the clinical presenta-
tions of SLE are wide- ranging and often nonspecific, making 
the diagnosis challenging, and emphasize the importance of 
continually reviewing the original diagnosis in cases with 
clinical uncertainty. The EULAR/ACR criteria assist in mak-
ing the diagnosis. Multisystem presentations can relate to a 
single unifying diagnosis or separate concomitant disease 
processes, and a multidisciplinary approach to management 
is beneficial to avoid delays to diagnosis.
ACKNOWLEDGMENTS
Thank you to the patient for allowing us to share her story.
CONFLICT OF INTEREST
The authors have no conflicts of interest.
AUTHOR CONTRIBUTIONS
AN, QZ, and PB: were part of the clinical team responsible 
for the patient's care during the reported presentation and con-
ceived and planned the report; AC: gave the pathology opinion; 
AN, QZ, and AC: collated the investigation results and biopsy 
images; all authors contributed to manuscript preparation.
ETHICAL APPROVAL
The patient gave written informed consent to publish the 
case.
DATA AVAILABILITY STATEMENT
Data sharing is not applicable as no new data were generated 
for this report.
ORCID
Ailish Nimmo   https://orcid.org/0000-0001-6044-5827 
REFERENCES
 1. Ramos- Casals M, Stone JH, Cid MC, Bosch X. The cryoglobulinae-
mias. Lancet. 2012;379(9813):348- 360. https://doi.org/10.1016/
S0140 - 6736(11)60242 - 0
 2. Damoiseaux J. The diagnosis and classification of the cryoglobu-
linemic syndrome. Autoimmun Rev. 2014;13(4):359- 362. https://
doi.org/10.1016/j.autrev.2014.01.027
 3. Morgan C, Bland AR, Maker C, Dunnage J, Bruce IN. Individuals 
living with lupus: findings from the LUPUS UK members survey 
2014. Lupus. 2018;27(4):681- 687. https://doi.org/10.1177/09612 
03317 749746
 4. Aringer M, Costenbader K, Daikh D, et al. 2019 European league 
against rheumatism/American college of rheumatology classifica-
tion criteria for systemic lupus erythematosus. Arthritis Rheumatol. 
2019;71(9):1400- 1412. https://doi.org/10.1002/art.40930
 5. Seo YS, Lee KG, Jung ES, et al. Clinical significance of the detec-
tion of antinuclear antibodies in patients with acute hepatitis a. Gut 
Liv. 2011;5(3):340- 347. https://doi.org/10.5009/gnl.2011.5.3.340
 6. Hillman M, Oren R, Zlotogorski A, Shouval D. Vasculitis and 
cryoglobulinemia associated with persisting cholestatic hepatitis A 
virus infection. Am J Gastroenterol. 1990;85(5):586- 587.
 7. Inman RD, Hodge M, Johnston MEA, Wright J, Heathcote J. 
Arthritis, vasculitis, and cryoglobulinemia associated with relaps-
ing hepatitis A virus infection. Ann Intern Med. 1986;105(5):700- 
703. https://doi.org/10.7326/0003- 4819- 105- 5- 700
 8. Stojan G, Baer AN. Flares of systemic lupus erythematosus during 
pregnancy and the puerperium: prevention, diagnosis and man-
agement. Exp Rev Clin Immunol. 2012;8(5):439- 453. https://doi.
org/10.1586/eci.12.36
 9. Bajema IM, Wilhelmus S, Alpers CE, et al. Revision of the inter-
national society of nephrology/renal pathology society classifica-
tion for lupus nephritis: clarification of definitions, and modified 
national institutes of health activity and chronicity indices. Kidney 
Int. 2018;93(4):789- 796. https://doi.org/10.1016/j.kint.2017.11. 
023
 10. Schwartz MM. The pathology of lupus nephritis. Semin 
Nephrol. 2007;27(1):22- 34. https://doi.org/10.1016/j.semne 
phrol.2006.09.005
 11. Shalit M, Wollner S, Levo Y. Cryoglobulinemia in acute type- A 
hepatitis. Clin Exp Immunol. 1982;47(3):613- 616.
 12. Morita M, Kitajima K, Yoshizawa H, et al. Glomerulonephritis as-
sociated with arteritis in marmosets infected with hepatitis A virus. 
Br J Exp Pathol. 1981;62(1):103- 113.
 13. Sethi S, Fervenza FC. Membranoproliferative glomerulonephritis 
— A new look at an old entity. N Engl J Med. 2012;366:1119- 1131. 
https://doi.org/10.1056/NEJMr a1108178
 14. Chen Y- P, Cheng H, Rui H- L, Dong H- R. Cryoglobulinemic vas-
culitis and glomerulonephritis: concerns in clinical practice. Chin 
Med J. 2019;132(14):1723- 1732.
How to cite this article: Nimmo A, Zhou Q, 
Chatzitolios A, Bailey P. Immunoglobulin and 
complement- mediated glomerular diseases with an 
MPGN pattern of injury: Unmasking the diagnosis of 
lupus in a patient with hepatitis A infection. Clin Case 
Rep. 2021;00:1– 5. https://doi.org/10.1002/ccr3.3949
